DCF — GRANDVIEW MEDICAL CENTER
Enterprise Value: $789.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$789.3M
Enterprise Value
$217.1M
PV of Cash Flows
$572.2M
PV of Terminal Value
$921.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $633.9M | $92.9M | 15.0% | $46.8M | $42.6M |
| Year 2 | $652.9M | $102.3M | 16.0% | $53.1M | $43.9M |
| Year 3 | $672.5M | $112.1M | 17.0% | $59.8M | $44.9M |
| Year 4 | $692.7M | $118.9M | 17.0% | $64.2M | $43.8M |
| Year 5 | $713.5M | $124.2M | 17.0% | $67.4M | $41.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $789.3M. Terminal value accounts for 72% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$615.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.14162114022947286
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5